Philippines Dialysis Market Report and Forecast 2024-2032
Philippines Dialysis Market Report and Forecast 2024-2032
Philippines Dialysis Market Overview
The Philippines dialysis market is estimated to grow at a compound annual growth rate (CAGR) of 5.2% from 2017 to 2032.The market is driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the country, which is attributed to the high incidence of diabetes, hypertension, obesity and aging population. According to the Philippine Renal Disease Registry, there were about 36,000 ESRD patients in 2017, of which 86% were undergoing dialysis treatment. The demand for dialysis services is expected to increase further as the number of ESRD patients is projected to reach 58,000 by 2022 and 95,000 by 2032.
Philippines Dialysis Market Drivers and Constraints
The Philippines dialysis market is also supported by the favorable government policies and initiatives, such as the Universal Health Care Act, the PhilHealth Z Benefit Package for ESRD, the National Kidney and Transplant Institute Act, and the Philippine Organ Donation and Transplantation Program. These policies and programs aim to improve the access, affordability and quality of dialysis care for the Filipino population, especially the poor and marginalized sectors. The government also provides subsidies and incentives for the establishment and operation of dialysis centers and facilities, as well as for the procurement and maintenance of dialysis equipment and supplies.
However, the Philippines dialysis market also faces several challenges and constraints, such as the limited availability and supply of dialysis machines, consumables and trained personnel, the high cost and out-of-pocket expenses of dialysis treatment, the low awareness and compliance of patients and caregivers, the lack of standardization and regulation of dialysis practices and quality, and the risk of infections and complications associated with dialysis. These factors hamper the growth and development of the market and pose significant barriers to the delivery and utilization of dialysis services in the country.
Philippines Dialysis Market Trends and Developments
The Philippines dialysis market is witnessing several key trends and developments that are shaping the market landscape and creating new opportunities and challenges for the market players. Some of the major trends and developments are:
- Rising Prevalence of Chronic Kidney Disease: The increasing incidence of CKD, mainly due to diabetes, hypertension, and other lifestyle-related diseases, is driving the demand for dialysis services in the Philippines.
- Government Initiatives: The Philippine government has implemented various initiatives to improve access to dialysis treatment, including the PhilHealth Z Benefit Package for kidney transplantation and the expanded Primary Care Benefit package, which covers outpatient dialysis services.
- Expansion of Dialysis Centers: There is a growing trend of expanding dialysis centers across the country, both in urban and rural areas, to cater to the increasing demand for dialysis services.
- Advancements in Dialysis Technology: The introduction of advanced dialysis machines and equipment, including portable and home dialysis systems, is improving the quality of care and convenience for patients.
- Public-Private Partnerships: Collaborations between the government and private sector are increasing to enhance the availability and affordability of dialysis services. This includes partnerships with private dialysis providers and non-profit organizations.
- Increasing Awareness and Early Detection: Efforts to raise awareness about kidney health and the importance of early detection of kidney disease are contributing to the earlier diagnosis and treatment of CKD, leading to increased demand for dialysis services.
Market Breakup by Type
- Hemodialysis
- Conventional Hemodialysis
- Short Daily Hemodialysis
- Nocturnal Hemodialysis
- Peritoneal Dialysis
- Continuous Ambulatory Peritoneal Dialysis
- Automated Peritoneal Dialysis
- Equipment
- Dialysis Machines
- Water Treatment Systems
- Others
- Consumables
- Dialyzers
- Catheters
- Others
- Dialysis Drugs
- Services
- In Center Dialysis
- Home Dialysis
The Philippines dialysis market is characterized by significant regional variations and disparities in terms of the availability, accessibility, affordability, and quality of dialysis services. The regional analysis of the market provides a comparative and comprehensive overview of the market performance, dynamics, and potential across the three major regions of the country: Luzon, Visayas, and Mindanao.
Philippines Dialysis Market Competitive Landscape
The Philippines dialysis market is highly competitive and fragmented, with the presence of numerous local and international players, both public and private, who offer a wide range of dialysis services, products, and solutions to the market. The competitive landscape of the market provides a detailed and comprehensive overview of the market structure, dynamics, and performance of the key players and stakeholders in the market.
Fresenius SE & Co. KGaA, Asahi Kasei Corporation, and B. Braun SE are renowned for their innovation and comprehensive solutions in dialysis care. Baxter and BD are pivotal in providing a range of dialysis products and technologies that enhance patient care. DaVita Inc. stands out for its dialysis services, offering patient-centric care across various settings.
AngioDynamics, Diaverum Deutschland GmbH, and Nikkiso Co., Ltd. are recognized for their specialized products and contributions to improving dialysis treatment outcomes. Nipro and Hemotek are instrumental in supplying essential dialysis consumables and equipment, supporting the infrastructure of dialysis care. The Nepro Group Dialysis Center and Dialife Group extend their services to meet the growing demand for accessible dialysis treatment. Medtronic and NxStage Medical, Inc. push the boundaries of innovation in dialysis technology, offering solutions that aim to improve the quality of life for those undergoing dialysis. Together, these organizations form a dynamic and essential part of the global dialysis market, driving forward improvements in care, technology, and accessibility for patients worldwide.
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Philippines Dialysis Market Overview
- 3.1 Philippines Dialysis Market Historical Value (2017-2023)
- 3.2 Philippines Dialysis Market Forecast Value (2024-2032)
- 4 Philippines Dialysis Market Dynamics
- 4.1 Market Drivers and Constraints
- 4.2 SWOT Analysis
- 4.2.1 Strengths
- 4.2.2 Weaknesses
- 4.2.3 Opportunities
- 4.2.4 Threats
- 4.3 Porter’s Five Forces Model
- 4.3.1 Bargaining Power of Suppliers
- 4.3.2 Bargaining Power of Buyers
- 4.3.3 Threat of New Entrants
- 4.3.4 Threat of Substitutes
- 4.3.5 Degree of Rivalry
- 4.4 Key Demand Indicators
- 4.5 Key Price Indicators
- 4.6 Industry Events, Initiatives, and Trends
- 4.7 Value Chain Analysis
- 5 Philippines Dialysis Market Segmentation
- 5.1 Philippines Dialysis Market by Type
- 5.1.1 Market Overview
- 5.1.2 Hemodialysis
- 5.1.2.1 Conventional Hemodialysis
- 5.1.2.2 Short Daily Hemodialysis
- 5.1.2.3 Nocturnal Hemodialysis
- 5.1.3 Peritoneal Dialysis
- 5.1.3.1 Continuous Ambulatory Peritoneal Dialysis
- 5.1.3.2 Automated Peritoneal Dialysis
- 5.2 Philippines Dialysis Market by Product & Services
- 5.2.1 Market Overview
- 5.2.2 Equipment
- 5.2.2.1 Dialysis Machines
- 5.2.2.2 Water Treatment Systems
- 5.2.2.3 Others
- 5.2.3 Consumables
- 5.2.3.1 Dialyzers
- 5.2.3.2 Catheters
- 5.2.3.3 Others
- 5.2.4 Dialysis Drugs
- 5.2.5 Services
- 5.3 Philippines Dialysis Market by End User
- 5.3.1 Market Overview
- 5.3.2 In Center Dialysis
- 5.3.3 Home Dialysis
- 6 Patent Analysis
- 6.1 Analysis by Type of Patent
- 6.2 Analysis by Publication Year
- 6.3 Analysis by Issuing Authority
- 6.4 Analysis by Patent Age
- 6.5 Analysis by CPC Analysis
- 6.6 Analysis by Patent Valuation
- 6.7 Analysis by Key Players
- 7 Grants Analysis
- 7.1 Analysis by Year
- 7.2 Analysis by Amount Awarded
- 7.3 Analysis by Issuing Authority
- 7.4 Analysis by Grant Application
- 7.5 Analysis by Funding Institute
- 7.6 Analysis by NIH Departments
- 7.7 Analysis by Recipient Organization
- 8 Funding Analysis
- 8.1 Analysis by Funding Instances
- 8.2 Analysis by Type of Funding
- 8.3 Analysis by Funding Amount
- 8.4 Analysis by Leading Players
- 8.5 Analysis by Leading Investors
- 8.6 Analysis by Geography
- 9 Partnership and Collaborations Analysis
- 9.1 Analysis by Partnership Instances
- 9.2 Analysis by Type of Partnership
- 9.3 Analysis by Leading Players
- 9.4 Analysis by Geography
- 10 Regulatory Framework
- 10.1 Regulatory Overview
- 11 Supplier Landscape
- 11.1 Fresenius SE & Co. KGaA
- 11.1.1 Financial Analysis
- 11.1.2 Product Portfolio
- 11.1.3 Demographic Reach and Achievements
- 11.1.4 Mergers and Acquisitions
- 11.1.5 Certifications
- 11.2 Asahi Kasei Corporation
- 11.2.1 Financial Analysis
- 11.2.2 Product Portfolio
- 11.2.3 Demographic Reach and Achievements
- 11.2.4 Mergers and Acquisitions
- 11.2.5 Certifications
- 11.3 B. Braun SE
- 11.3.1 Financial Analysis
- 11.3.2 Product Portfolio
- 11.3.3 Demographic Reach and Achievements
- 11.3.4 Mergers and Acquisitions
- 11.3.5 Certifications
- 11.4 Baxter
- 11.4.1 Financial Analysis
- 11.4.2 Financial Portfolio
- 11.4.3 Demographic Reach and Achievements
- 11.4.4 Mergers and Acquisitions
- 11.4.5 Certifications
- 11.5 BD
- 11.5.1 Financial Analysis
- 11.5.2 Product Portfolio
- 11.5.3 Demographic Reach and Achievements
- 11.5.4 Mergers and Acquisitions
- 11.5.5 Certifications
- 11.6 DaVita Inc.
- 11.6.1 Financial Analysis
- 11.6.2 Product Portfolio
- 11.6.3 Demographic Reach and Achievements
- 11.6.4 Mergers and Acquisitions
- 11.6.5 Certifications
- 11.7 AngioDynamics
- 11.7.1 Financial Analysis
- 11.7.2 Product Portfolio
- 11.7.3 Demographic Reach and Achievements
- 11.7.4 Mergers and Acquisitions
- 11.7.5 Certifications
- 11.8 Diaverum Deutschland Gmbh
- 11.8.1 Financial Analysis
- 11.8.2 Product Portfolio
- 11.8.3 Demographic Reach and Achievements
- 11.8.4 Mergers and Acquisitions
- 11.8.5 Certifications
- 11.9 Nikkiso Co., Ltd.
- 11.9.1 Financial Analysis
- 11.9.2 Product Portfolio
- 11.9.3 Demographic Reach and Achievements
- 11.9.4 Mergers and Acquisitions
- 11.9.5 Certifications
- 11.10 Nipro
- 11.10.1 Financial Analysis
- 11.10.2 Product Portfolio
- 11.10.3 Demographic Reach and Achievements
- 11.10.4 Mergers and Acquisitions
- 11.10.5 Certifications
- 11.11 Hemotek
- 11.11.1 Financial Analysis
- 11.11.2 Product Portfolio
- 11.11.3 Demographic Reach and Achievements
- 11.11.4 Mergers and Acquisitions
- 11.11.5 Certifications
- 11.12 Nepro Group Dialysis Center
- 11.12.1 Financial Analysis
- 11.12.2 Product Portfolio
- 11.12.3 Demographic Reach and Achievements
- 11.12.4 Mergers and Acquisitions
- 11.12.5 Certifications
- 11.13 Dialife Group
- 11.13.1 Financial Analysis
- 11.13.2 Product Portfolio
- 11.13.3 Demographic Reach and Achievements
- 11.13.4 Mergers and Acquisitions
- 11.13.5 Certifications
- 11.14 Medtronic
- 11.14.1 Financial Analysis
- 11.14.2 Product Portfolio
- 11.14.3 Demographic Reach and Achievements
- 11.14.4 Mergers and Acquisitions
- 11.14.5 Certifications
- 11.15 NxStage Medical, Inc.
- 11.15.1 Financial Analysis
- 11.15.2 Product Portfolio
- 11.15.3 Demographic Reach and Achievements
- 11.15.4 Mergers and Acquisitions
- 11.15.5 Certifications
- 12 Philippines Dialysis Market - Distribution Model (Additional Insight)
- 12.1 Overview
- 12.2 Potential Distributors
- 12.3 Key Parameters for Distribution Partner Assessment
- 13 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 14 Company Competitiveness Analysis (Additional Insight)
- 14.1 Very Small Companies
- 14.2 Small Companies
- 14.3 Mid-Sized Companies
- 14.4 Large Companies
- 14.5 Very Large Companies
- 15 Payment Methods (Additional Insight)
- 15.1 Government Funded
- 15.2 Private Insurance
- 15.3 Out-of-Pocket
- *Additional insights provided are customisable as per client requirements.
- * The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook